A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS...
Our news web pages include ground-breaking multiple sclerosis news and research from around the world.
These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.
Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.
We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years.
A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS...
Of 1,000 women diagnosed with relapsing remitting multiple sclerosis (RRMS) in the last five years, 88% were concerned they would not be able to have children, despite studies that show otherwise...
Biopharmaceutical Company MediciNova has announced additional positive clinical data from its SPRINT-MS phase IIB trial of MN-166 (ibudilast) in progressive multiple sclerosis (PMS).
MN-166...
According to a study, published in the 31 January 2018 online edition of Neurology, the medical journal of the American Academy of Neurology, a special programme of balance and eye movement...
The Dutch Medicines Evaluation Board has signed off AXIM Biotechnologies’ MedChew Rx clinical development programme, which will see them develop and trial a cannabis based chewing gum.
The...
It is difficult to identify patients at risk of disease reactivation. So in a recent study scientists at Cerrahpasa School of Medicine, Istanbul University in Turkey compared the demographic and...
Researchers from Monash University in Australia are set to conduct a large study into a drug that may one day help halt the progression of multiple sclerosis (MS).
The preclinical study,...
A study, published at ECTRIMS 2017, has revealed that serum vitamin D levels could be involved in the regulation of the replication/reactivation of Epstein-Barr virus (EBV) in multiple sclerosis (...
An international team of researchers led by Professor Savvas Savvides, VIB-UGent Center for Inflammation Research, has unravelled a crucial aspect of the molecular basis of autoimmune and...
The U.S Food and Drug Administration (FDA) has denied a request for healthy individuals to consume vitamin D to reduce the risk of developing multiple sclerosis (MS).
The FDA reviewed 85...